John Milligan
Chairman at PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Net worth: 4 M $ as of 2024-03-30
John Milligan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Independent Dir/Board Member | 2013-07-17 | - |
| Chairman | 2020-09-13 | - | |
| Director/Board Member | 2013-07-17 | 2020-09-13 | |
| 4D MOLECULAR THERAPEUTICS, INC. | Chairman | 2020-07-31 | - |
| Independent Dir/Board Member | 2020-07-31 | - | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 2011-07-21 | - |
| Ohio Wesleyan University | Chairman | - | - |
Career history of John Milligan
Former positions of John Milligan
| Companies | Position | Start | End |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Director/Board Member | 2016-01-27 | 2018-12-30 |
| Chief Executive Officer | 2016-03-09 | 2018-12-30 | |
| Chief Operating Officer | 2006-12-31 | 2016-03-09 | |
| President | 2007-12-31 | 2018-12-30 | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | President | 2012-01-12 | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 1995-12-31 | - |
Training of John Milligan
| Ohio Wesleyan University | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Statistics
International
| United States | 9 |
Operational
| Chairman | 4 |
| Director/Board Member | 3 |
| President | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Stock Market
- Insiders
- John Milligan
- Experience
